Arcus Biosciences, Inc. (RCUS)
29.66
-0.47
(-1.56%)
USD |
NYSE |
Sep 04, 16:00
29.66
0.00 (0.00%)
Pre-Market: 20:00
Arcus Biosciences Cash and Short Term Investments (Annual) : 981.00M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 981.00M |
| December 31, 2024 | 978.00M |
| December 31, 2023 | 759.00M |
| December 31, 2022 | 1.009B |
| December 31, 2021 | 499.31M |
| Date | Value |
|---|---|
| December 31, 2020 | 728.65M |
| December 31, 2019 | 188.27M |
| December 31, 2018 | 256.54M |
| December 31, 2017 | 175.70M |
| December 31, 2016 | 98.90M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Halozyme Therapeutics, Inc. | 142.82M |
| AVITA Medical, Inc. | 18.18M |
| Iovance Biotherapeutics, Inc. | 296.98M |
| Editas Medicine, Inc. | 146.64M |
| Recursion Pharmaceuticals, Inc. | 747.89M |